Adaptive Approach to Neoadjuvant Therapy to Maximize Resection Rates for Pancreatic Adenocarcinoma

NCT04594772 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Pancreas Cancer

Interventions

DRUG: Folfirinox
DRUG: Gemcitabine
RADIATION: radiation therapy
PROCEDURE: Pancreatectomy

Sponsor

University of Cincinnati